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Abstract: More than two hundred years after its discovery, lactate still remains an intriguing molecule.
Considered for a long time as a waste product of metabolism and the culprit behind muscular fatigue,
it was then recognized as an important fuel for many cells. In particular, in the nervous system, it has
been proposed that lactate, released by astrocytes in response to neuronal activation, is taken up by
neurons, oxidized to pyruvate and used for synthesizing acetyl-CoA to be used for the tricarboxylic
acid cycle. More recently, in addition to this metabolic role, the discovery of a specific receptor
prompted a reconsideration of its role, and lactate is now seen as a sort of hormone, even involved
in processes as complex as memory formation and neuroprotection. As a matter of fact, exercise
offers many benefits for our organisms, and seems to delay brain aging and neurodegeneration. Now,
exercise induces the production and release of lactate into the blood which can reach the liver, the
heart, and also the brain. Can lactate be a beneficial molecule produced during exercise, and offer
neuroprotection? In this review, we summarize what we have known on lactate, discussing the roles
that have been attributed to this molecule over time.
Keywords: lactic acid; brain metabolism; lactate transporters; blood-brain barrier; lactate receptors;
exercise and lactate
1. Introduction
Carl Wilhelm Scheele, an 18th century Swedish chemist, also known for his role in the discovery
of oxygen, purified many organic acids, among which lactic acid (LA).
About one hundred years later, in their study on the regulation of the blood supply to the brain,
Roy and Sherrington reported that cerebral anemia, experimentally obtained by closing the carotid and
vertebral arteries, was immediately accompanied by an acid reaction in the cortex; then, after reopening
the cerebral vessels, the acidity gradually disappeared. The Authors attributed the observed effects to
the formation of (ethylidene) lactic acid [1]. In the following years, it was proposed that LA increased
during muscle exercise because of an oxygen debt, determined by the high energy requirement of
contraction [2–4]. In glycolysis, indeed, glucose is broken down to twomolecules of pyruvate; pyruvate
then either enters the mitochondria, where it is further oxidized in the tricarboxylic acid (TCA) cycle,
or is reversibly reduced by NADH(H+)-dependent lactic dehydrogenase (LDH) to lactic acid, in order
to regenerate NAD+ for glycolysis. Shortage of oxygen, by slowing down mitochondrial oxidative
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phosphorylation, and hence TCA cycle, causes an increase of lactate production. In order to limit cell
acidification, both lactate and protons then exit cells.
By the end of the fifties, it was clear that hypoglycaemia, by limiting the supply to the brain of
its preferred metabolic substrate (i.e., glucose), could reduce cell respiration/energy production and
hence brain electric activity. It was also clear that, upon electrical stimulation, the metabolic activity of
the brain could be increased and, as a consequence, more glucose and oxygen were taken from the
blood, with a parallel increase of carbon dioxide and lactate released into the blood [5]. Moreover,
electrical stimulation of brain tissue rendered it more susceptible to a fall in glucose level, and the same
effect was noticed for the aerobic accumulation of LA [6]. These observations suggested that neuronal
activity needs to be coupled to an efficient uptake of oxygen and metabolites from the circulation, and
that the blood flow itself should be modulated locally in response to variations of neuronal activity [7].
In the following decades, the possibility emerged that cells in the brain itself, namely astrocytes, can
transfer to neurons molecules, such as glucose and/or lactate, to sustain increased energy requirements,
both in physiological and pathological conditions. Here, we’ll discuss how ideas on the production
and utilization in the brain of LA have changed over time from identification of lactate as a metabolic
product of glucose metabolism to acknowledgement of its regulatory functions.
2. Exercise, Lactate Production in the Periphery and Fatigue
2.1. Exercise and Lactate Production
In muscle cells, during intense exercise, ATP is mainly generated from blood glucose and muscle
glycogen to fuel glycolysis. This latter pathway is still considered the fastest, but produces less
ATP compared to phosphagen systems and to the cellular respiration (oxidative phosphorylation,
OXPHOS) [8]. ATP, the fuel used for contraction, is usually present in cells at a concentration of
8 mmol/kg of wet weight of muscle [9]. On the other hand, accumulation of pyruvate, not used
for OXPHOS, should inhibit glycolysis because of shortage of NAD+; to overcome this situation, in
anaerobic conditions (hypoxia), a large part of pyruvate is reduced to lactate by lactate dehydrogenase
enzyme, thus oxidizing NADH(H+) back to NAD+. Noteworthy, during intense physical activity, lactic
acid, that is a strong organic acid, mainly exists, like pyruvate, as an anion at the human body pH
values. In other words, due to its pKa (3.86), lactic acid is physiologically deprotonated and exists as
lactate and H+ [10].
In addition, lactate can be also considered an aerobic metabolite, usable by skeletal muscles and by
the heart when the oxygen availability is adequate, and it may contribute to acetyl-CoA formation [11].
A large part of muscle-derived lactate is transported to the liver where it is used to synthesize glucose
through gluconeogenesis; glucose then enters the blood flow and comes to the muscles to be used as
a metabolite in glycolysis (Cori’s cycle). In the last decade, it has been discovered that adipocytes can
also produce lactate under anaerobic circumstances. It has been suggested that, in order to counteract
O2 shortage, adipocytes switch to glycolytic metabolism, and to avoid a dramatic intracellular pH
decrease, protons are removed from the cell thanks to proton-linked monocarboxylate transporters
(MCTs; isoforms 1 and 4; see next section) [12]. The total amount of lactate produced by adipocytes
depends on the fat mass: it is indeed higher in obese subjects than in normal-weight individuals.
A large part of lactate produced from active muscles is released and taken up by exercising and
non-exercising muscles, heart and brain, to be oxidized and used as a fuel [13]. More than 30 years
ago, Brooks introduced the concept of lactate shuttle through which lactate might be carried into
mitochondria or peroxisomes, through MCTs, to be reoxidized, or even out into the bloodstream
to be taken up from other organs which could use it as a fuel [14]. In sports medicine, the highest
level of physical effort that the body can sustain without accumulating lactate and hydrogen ions
(H+) in blood and muscles is called anaerobic threshold or lactate threshold; this threshold also
corresponds to the intensity/duration of physical activity that the energy metabolism supports without
switching from aerobic to anaerobic. Lactate threshold provides a good fitness level and is considered
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the best performance predictor. Intense training increases lactate threshold and, finally, increases
performance [15].
Hypoxia can be induced by intense exercise as well as by altitude exposure (2300–5700 m);
the latter induces skeletal muscle adaptations, such as transport of bicarbonate, hydrogen ions, and
lactate, all of which are finely regulated. Oxygen shortage stimulates glycolysis and can increase
pyruvate availability. This may be used for further oxidation in mitochondria or to increase lactate
production. As a result of hypoxia, there is a higher amount of lactate production for a given workload.
Muscular energy comes more from carbohydrates than fatty acids. Altitude-induced hypoxia leads to
the lactate paradox, defined as “reduced blood lactate concentrations during submaximal and maximal
exercise following acclimatization to high altitude” [16]. An interesting hypothesis is that altitude
acclimatization may be due to a reduced “muscle recruitment” probably aimed at “protecting” cerebral
oxygenation; in other words, the paradox of lactate, observed in chronic hypoxia, should be due to
reduced muscle recruitment imposed by the central nervous system, that reduces the transport of O2
to muscles and muscle contraction to protect itself from dangerous hypoxia [16,17].
2.2. Fatigue
A parallel interesting matter concerns “fatigue”, a condition of rapid deterioration of contractile
function, caused by intense exercise. Keeping ATP levels is essential in carrying out the physiological
functions of the body. Muscle fatigue is possibly necessary to avoid that ATP range falls below critical
or irreversible levels, and it is logical to assume a causal relationship between anaerobic metabolism
and muscle fatigue [18]. The shift from aerobic to anaerobic metabolism is probably responsible for
the sudden increase in lactate levels in blood and, even before, at the intracellular level, for metabolic
acidosis [19]. Acidosis seems to impair muscle contraction, leading to fatigue and, ultimately, to
cessation of exercise. The uncomfortable feelings associated with acidosis has long been associated
with the pain (now commonly referred to as delayed onset muscle soreness, or DOMS) of the days after
intense exercise. Lactate production through the glycolytic pathway is associated with hydrogen ions
(H+) production: in particular, two ions are released if glycolysis uses blood glucose, while one ion is
released if glycogen is used [20]. Thus, lactate is not necessarily the source of the H+ increase, which
might indeed derive from glycolysis [21]. Historically, the accumulation of lactic acid in muscles has
been suggested as the main cause of muscle fatigue. Lactate and H+ ions are produced in muscles
during intense exercise, and in humans, the intracellular lactate concentration may reach 30 mM or
more. Nevertheless, the intracellular pH only decreases of approximately 0.5 units, due to the body
buffering capacity. In these conditions, an increase of extracellular osmolarity should be observed,
which causes a water movement out of the muscle fibers, and thereby an increase of the intracellular
ionic strength. The overall result should be an inhibitory effect on force production [22,23]. On the other
hand, acidification per se seems to have a low effect on the reduced fiber shortening velocity linked to
fatigue. Lactic acid production plays indeed a metabolic buffering action rather than determining the
onset of acidosis. As a matter of fact, the reaction catalyzed by lactate dehydrogenase uses two electrons
and one proton from NADH and a second proton from the cytosol to reduce pyruvate to lactate [24].
In summary, the muscle lactate production is essential for the buffering effect as well as to regenerate
NAD+, at the same time serving to remove the extra pyruvate [9]. A further mechanism by which
intracellular acidosis might induce fatigue is through inhibition of key enzymes of glycogenolysis and
glycolysis, such as glycogen phosphorylase and phosphofructokinase, both of which are inhibited by
low pH, at least in vitro [25].
Another system responsible for ATP synthesis in working muscles involves the phosphagens.
During intense exercise, the main substrate used is creatine phosphate (CrP). The reaction catalyzed by
creatine kinase uses protons (H+), thus causing a faint alkalization of the muscle cell. The effect of this
reaction is to counteract the slight acidosis induced by glycolysis and lactic acid formation [26].
Muscle contraction also causes an increase of phosphate (Pi) levels, which has a direct effect
on myofibrils and/or an effect on the pathway of excitation/contraction of muscle cells [27].
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Several studies suggest that an elevated muscle [H+] as well as high [Pi] could impair muscle function
by reducing (i) the transition of miofibrils to high cross-bridged states; (ii) the maximal shortening
velocity; (iii) the glycolytic rate; (iv) cross-bridging activation, by competitively inhibiting Ca2+ binding
to troponin C [4,28,29].
It is not yet clear which effect has the predominant role in fatigue; probably, all the mentioned
factors are involved, and play a synergistic effect, thus leading to impaired contraction and
muscle strength.
3. Lactate Uptake across the Blood-Brain Barrier and Monocarboxylate Carriers (MCTs)
3.1. Lactate Can Cross the Blood-Brain Barrier (BBB)
During the eighties, the idea that lactic acid (LA) was only a dead-end waste product of anaerobic
metabolism began being challenged by many converging observations [4]. First of all, as mentioned, it
was realized that LA can be shuttled both between and within the cells. The most relevant output of
LA from cells was bound to sustained exercise. This process was defined by Brooks [14] as the “lactate
shuttle”. LA is indeed released from muscles during short-term exercise, and even from muscles at
rest, during recovery from short-term exercise, and during long-lasting exercise. However, LA can be
taken up from blood into either resting or slowly working muscles [4]. Actually, in the same muscle,
glycolytic fibers can produce and release LA which can be, at least in part, taken up by surrounding
oxidative fibers and again converted to pyruvate for further aerobic oxidization.
As we will discuss later, a relevant case of intercellular lactate shuttle should be that established
among glial cells (especially astrocytes) and neurons, which could be considered one of the many
aspects of the glial–neuronal metabolic coupling.
In addition to intercellular lactate shuttling, intra-cellular shuttling has been also suggested.
In particular, muscular mitochondria were reported to contain a monocarboxylate transporter (MCT1,
see below), able to allow LA entrance, as well as lactic dehydrogenase, which converts lactate back to
pyruvate. This reaction also transfers electrons to NAD+, thus also shuttling electrons from the cytosol
to the mitochondrion [4,30,31].
A further indication that lactate is not only a waste product of anaerobic metabolism, produced in
conditions of oxygen shortage, but instead a potentially useful fuel, came from the observation that
the blood brain barrier (BBB) can be crossed by lactate. The brain is indeed isolated and protected
from compounds circulating in the blood by a layer of brain capillary endothelial cells (BCECs) with
peculiar properties [32]. BCECs are sealed together by tight junctions (TJs) which block para-cellular
fluxes of molecules. Thus, in order to enter the brain, molecules have to be either soluble in plasma
membrane lipids (and not actively extruded by ATP-dependent transporters: ABC transporters), or
to be recognized by transporters, able to mediate trans-cellular crossing of the BCEC layer [32–35].
In addition, to ensure trans-cellular transport, a synergic cooperation between the two membranes of
endothelial cells is required [36].
3.2. The Monocarboxylate Carriers (MCTs)
Lactate entrance into the brain is mediated by BBB transporters which belong to the
monocarboxylate carrier (MCT) family, and also transport other monocarboxylic acids, such as
pyruvate and ketone bodies. MCTs form a family of 14 transmembrane proteins [37,38], which belong
to the solute carrier family (SLC16), and for many of which endogenous functions and substrates still
await to be discovered. Actually, lactate transport across the cell plasma membranes of the body can
use either sodium-coupled transporters (SMCTs) or proton-coupled monocarboxylate transporters
(MCTs) [13]. In the brain, lactate transport involves MCTs. In particular, four carriers (MCTs 1–4)
have been characterized which catalyze bidirectional, electroneutral 1:1 co-transport of protons and
monocarboxylic acids [13,37–40]. All of them can transport lactate, with different affinities, the one with
the highest affinity being MCT2 (Km: about 0.7 mM). MCT1 is expressed in a variety of human tissues,
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including brain, and is involved in brain uptake of lactate across the BBB both in mice and humans [41].
MCT2, first reported to be expressed in astrocytes, has been then demonstrated to be primarily present
in neurons, and, more precisely, in postsynaptic elements of glutamatergic synapses, where it has
been suggested to provide increased supply of lactate “as energy fuel” during neuronal increased
activity [39]. MCT3 is preferentially expressed in the basolateral membrane of the retinal pigment
epithelium (RPE), and plays an important role in regulating pH and lactate concentration in the outer
retina [42]. Finally, MCT4 (Km: about 35 mM) seems to be restricted to the plasma membrane of
astrocytes, where it localizes to both perisynaptic processes and perivascular endfeet [39]. The different
localization of the MCTs in the brain suggests that each species might be involved in different aspects of
lactate metabolism, possibly involving differences in the preferential direction of inter-cellular lactate
transport. The role of these transporters might change under different conditions. It has been reported,
for example, that oxygen- and glucose-deprivation (OGD) increases cell death in cultured neurons,
and up-regulates expression of MCT4 in astrocytes. If, however, cell cultures are exposed to MCT4- or
MCT2-specific siRNAs, thus significantly reducing their expression, neuronal cell death increases,
unless lactate is added to the culture medium before OGD [43]. Moreover, expression of MCTs has
been found to be perturbed in some pathological conditions, such as epilepsy [41]. The MCTs have
different Km for lactate, thus probably contributing to the specific tendency of each cell type in a tissue
to transport lactate out of or into the cell. It is, however, to be pointed out that the proton gradient is
also important [39].
Interestingly, membrane localization and activity of MCTs also require accessory proteins, such as
neuroplastin, basigin and embigin [44–46], that chaperone their transport to the membrane as well as
their function.
Recently, MCT1, MCT2, and MCT4 have been shown to be expressed also in the peripheral
nervous system (PNS), with different cell- and domain-distribution: myelinating Schwann cells (SCs)
express both MCT1 and MCT4, but in different compartments, while neurons of the dorsal root
ganglion express MCT1. Interestingly, downregulation of MCT1 expression can increase myelinating
activity in SCs and decrease neurofilament synthesis in neurons [47]. Moreover, the Authors found
that lactate homeostasis participates in the regulation of SC myelinating program [47].
4. Glial Cell—Neurons Lactate Shuttle and Brain Energy Metabolism
4.1. Lactate Shuttling and Energy Metabolism
In the last two decades it has become increasingly clear that glial cells have more functions
and are more dynamic than previously expected. Astrocytes, in particular, constitute with neurons
a highly integrated complex in which each astrocyte contacts many neurons, and many astrocytes
are coupled to each other through astroglial intercellular networks based on gap junction channels
(GJ) [48–50], formed by connexins (C ⇥ 43 and C ⇥ 30) [51–53]. Importantly, astroglial networks
are involved in several control functions, such as ionic homeostasis and control of cell volume;
they seem to finely tune neuronal circuits, by delivering to neurons energy metabolites in neuronal
activity-dependent manner [49], as also suggested by their distribution and proximity to excitatory
synapses [54]. Moreover, C⇥ 43 hemichannels have been reported to allow diffusion of gliotransmitters
(for example, glutamate or ATP) [55,56], thus mediating signaling events which seem to be important
also for functions as complex as memory consolidation [57], and recovery after ischemic injury [58].
Formation of an astrocytic network also allows generation of a glucose gradient, from the highest
concentrations close to the BBB, where glucose uptake at astrocytic feet is maximal, to the lowest
concentrations at the level of neuron-astrocyte contacts. Along this gradient, glucose can rapidly move
toward the regions at which neuronal activity and hence metabolic demand are higher. Astrocytes are
also able to store glucose as glycogen, and it has been proposed that this glycogen is metabolized and
supports neuronal activity in conditions of glucose shortage, triggered by a variety of causes [59–63].
Interestingly, glycogen is located in myelinating Schwann cells in the mouse sciatic nerve which is
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also able to release lactate, thus suggesting that glycogen plays a similar metabolic role in central and
peripheral nervous system [64].
Finally, and most important, since many years ago, the existence of an astrocyte-neuron lactate
shuttle (ANLS), which should be particularly active during excitatory neurotransmission, has been
suggested [65]. In detail, the hypothesis moved from the observation that glutamate released from
glutamatergic axon is taken up by both neurons, and astrocytes which surround the synapse. Glutamate
uptake is mediated by a sodium-dependent carrier and triggers an increase of the Na+/K+-ATPase
activity; by consuming ATP this process stimulates glycolysis, glucose utilization, and lactate
production [65–68]. Then, lactate should be delivered to neurons through the MCTs present in both
astrocytes and neurons. Finally, neurons should convert lactate to pyruvate and use it for synthesizing
acetyl-CoA, and fueling the tricarboxylic acid cycle. At the same time, ATP is used in astrocytes to
convert glutamate to glutamine which is released to neurons as well [69].
The central, andmost important, point of the ANLSmodel is the neuronal use of astrocyte-derived
lactate instead of glucose. Actually, even before the proposal of the lactate shuttle hypothesis, it had
been demonstrated that brain slices in culture were able to maintain normal synaptic function using
lactate as the only energy source [70], and that lactate, not glucose, was necessary to neurons during
recovery from hypoxic conditions [71,72]. Moreover, as discussed by Schurr [73], the idea that brain
tissue could oxidize lactate was even older and dates back to the thirties [74–78].
A further important aspect of the ANLS theory is the idea that lactate can come from glial
cells [79–81]. There is some debate, however, on the origin of this lactate: as already mentioned,
the original theory moved from glutamate recovery from the synapse [7,82]. An alternative
proposal was that lactate derives from glycogen stored in astrocytes [83,84]. In contrast, it has
also been suggested that it derives from slow oxidation of glutamate released from astrocytes in
a calcium-dependent manner, and not from glutamate released during glutamatergic neuronal
activation [85]. Further controversy concerns the real importance, under physiological conditions, of
lactate released from astrocytes for neuronal metabolism [61,86]. It has been proposed, for example, that
glycogenolysis’ main function in astrocytes is to maintain a high concentration of glucose-6-phosphate,
thus inhibiting hexokinase and sparing glucose; this latter could be thus diverted to neurons [62].
A fundamental question is which cell type (neurons or glial cells) uses more glucose? Under resting
conditions, about one half of glucose seems to be taken up by neurons and one half by astrocytes.
However, the energy required by astrocytes accounts for about 10%–15% of total energy needed
in the brain, and that required by neurons for about 60% or more. This observation suggests that:
(i) astrocytes use glucose mainly for anaerobic glycolysis; and (ii) neurons should use something else
besides glucose [87]. Lactate might be the substrate produced in astrocytes and used in neurons, as
shown at least in vitro [88–92]. Intriguingly, an opposite flux of metabolites (lactate and aspartate) from
neurons to Muller glia has been reported in mouse retinas [93]. In addition, experimental evidence
has been reported that, during neuronal activation, both neurons and astrocytes can oxidize glucose
as well as lactate, and that considerable lactate production might be neuronal [94–100]. In agreement
with the ANLS hypothesis, it has been found that exposure to metabolic stress induces the rapid
release from neurons of tissue-type plasminogen activator (tPA). In this case tPA does not induce
cleavage of plasminogen but, instead, AMPK activation and recruitment to the membrane of GLUT-1,
in both astrocytes and endothelial cells. Uptake and metabolism of glucose is followed by production
and release of lactate, which is then captured by neurons through the MCT-2 [101]. Interestingly,
astrocyte-neuron lactate transport has also been suggested to be required for long-term memory
formation (see below); in particular, it seems that, during the most intense cognitive activities in the
hippocampus, astrocytic glycogenolysis is stimulated and provides lactate, which is then transferred
to neurons as an energy surplus when glucose is not sufficient [102,103]. In agreement with this idea,
it has been recently reported that, in response to local neuronal activation, lactate is released from
astrocytes through a K+-stimulated anion channel [104].
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On the other hand, other researchers reported that, during neuronal activity in hippocampal slices,
glucose is the effective energy substrate for both neurons and astrocytes [105,106]. The mentioned
controversies could be at least partially solved if lactate is not only a metabolic substrate but also
a signaling molecule (see below).
4.2. Glucose Sensing
A particularly interesting topic concerns the ability of the brain to “sense” glucose concentration.
This ability primarily involves the hypothalamus, the part of the brain able to organize adaptive
responses by modulating different functions, among which hormone production, which in turn
regulates food intake and peripheral organ activities. In contrast with other brain regions,
hypothalamus (and in particular the arcuate nucleus, ARC) is not completely separated from circulation
by the BBB and spaces permeable to ions and nutrients are present, close to the nutrient-sensitive
neurons [50,107]. Central glucose sensing, in turn, controls neuronal signaling cascades which regulate
peripheral hormone-dependent glucose uptake and metabolism [108].
Glucose-sensitive neurons were discovered about 50 years ago [109,110] and their mechanisms
of action have been further characterized by ex vivo electrophysiological studies [50]. Recently,
the mechanisms underlying glucose sensitivity have been better clarified with the discovery that
astrocytes, and specifically connexins, are also involved [111]. Although the main cerebral forms
of glucose transporters are the high-affinity ones (GLUT1 and GLUT3), similarly to pancreatic beta
cells, hypothalamus glucose sensitivity relies on GLUT2 glucose transporter and on the ability of
hexokinase IV (glucokinase, GK) to phosphorylate glucose, without being inhibited by its end-product,
glucose-6-phosphate. GK is expressed in selected neuronal populations of hypothalamus [108,112], and,
in addition, it has been reported to form a mitochondrial complex with proteins involved in apoptosis
control [113]. On the other hand, GLUT2 is mainly present in hypothalamic astrocytes [114,115], thus
suggesting that these cells have an important role in sensing glucose concentration. Interestingly, it has
been reported that glucose-sensing neurons can also be activated by lactate [116,117], and one possible
view is that they sense, at least in part, not directly glucose, but lactate released by astrocytes [50].
4.3. Role of Extracellular Vesicles (EVs) in Cell-to-Cell Communications in the Brain
Finally, a short mention should be made on the molecule exchange among brain cells, which
involves extracellular vesicles (EVs), either ectosomes or exosomes. Both neurons [118] and
astrocytes [119] in culture can release into the medium extracellular vesicles (EVs) which contain, for
example, angiogenic factors [118,119], molecular chaperones [120], and synapsin I [121]. This mode
of communication is fundamental for tumor cells, including brain cancer cells, for invasion and
migration [122–124], but it could also have an important role in normal brain cells. Brain cells have
indeed the ability to grow branched cellular processes which explore the environment and establish
several contacts with other cell types. Interestingly, in vitro studies showed that synaptic activity can
potentiate release of exosomes from neurons [125], and that exosomes can be involved in synaptic
plasticity and long-term memory [126]. EVs are also released from oligodendrocytes and it has been
reported that these vesicles can contain molecules of metabolic interest, among which lactate [127–129].
5. Lactate as a Substrate during Exercise and in Memory Processes
A growing body of evidence suggests that mild, but regular, physical activity can be beneficial to
neuronal survival and plasticity. This observation is especially important in older people. It is indeed
clear that increasing age is associated with decreasing cognitive functions, and increasing risk of
dementia. It has been reported for example that the number of deaths from Alzheimer’s disease (AD)
increased by 68% from 2000 to 2010, in spite of a drastic reduction of mortality from cardiovascular
disease and stroke [130]. In general, brain volume decreases with aging. Cognitive decline has been
attributed to changes in both neuronal and non-neuronal populations within the CNS, including
deterioration of the blood–brain barrier (BBB) [131]. Physical activity seems to ameliorate cognition
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processes, and counteract brain aging [132,133]. The cellular events responsible for these effects have
been, however, only partially characterized.
As expected, during exercise, brain blood flow increases, and this elevation is due to an increase
in cardiac output, but probably also to changes in brain metabolism [134]. For example, brain glycogen
stored in astrocytes decreases during prolonged exercise with hypoglycemia, and this effect has
been attributed to activation of the transduction pathways triggered by noradrenaline and
serotonin [135–137]. By using an acute intense exercise model of swimming in rats, Matsui et al. [63]
also showed that glycogen decreases also in the absence of hypoglycemia, and that its decrease
associates with increased lactate in hippocampus, cerebellum, cortex and brain stem [63].
Since glycogen is essentially stored in astrocytes, it is likely that the increase of lactate is due to
astrocytic activity. As mentioned, it has been suggested that astrocyte-neuron lactate transport
is also important for memory formation [102,103,138]. Could lactate be the link between exercise
and improvement of cognitive functions? One of the factors that link exercise and memory seems
to be brain-derived neurotrophic factor (BDNF) [139–141]. Animal studies have shown that this
neurotrophin is essential for long-term potentiation (LTP) and neuroplasticity [142–144]. Moreover,
pharmacological blockade of BDNF expression hampers the ability to acquire and retain novel spatial
information in rats exposed to exercise [145]. Notably, human studies have confirmed that circulating
levels of BDNF are transiently increased with exercise [146,147]. Mild exercise can also stimulate
hippocampal neurogenesis [148]. However, the biochemical mechanisms underlying the link between
exercise-related peripheral BDNF increases and memory improvements in humans remain to be
clarified. Two other growth factors are probably involved in the effects of exercise on neuroplasticity:
insulin-like growth factor 1 (IGF-1) [149–151] and vascular endothelial growth factor (VEGF) [141].
VEGF could have a direct effect on BBB function and, in turn, on oxygen and glucose uptake to the brain,
while, interestingly, both IGF-1 and BDNF seem to stimulate neurogenesis, through a signaling cascade
that includes calmodulin-dependent protein kinase II (CAMK-II), an enzyme likely involved in long
term potentiation [152,153]. CAMK-II is regulated by calcium ions and calmodulin (CaM). In neurons,
CaM also interacts with small IQ domain proteins (SNIQ), such as neuromodulin, neurogranin, and
PEP-19 [154–157]. SNIQ have the potential to modulate the amount/localization of calmodulin which
can interact with, and activate CAMK-II. This raises the interesting possibility that IQ domain proteins
might provide at least some of the still unknown regulatory links between calcium metabolism in the
brain and cognitive functions, in both normal and pathological conditions. For example, CAMK-II
might phosphorylate RNA-binding proteins which are part of pre-localized ribonucleoparticles (RNPs);
phosphorylation of these proteins should then allow translation of specific mRNAs only at the level
of activated synapses, thus participating in their potentiation [158]. Notably, at least one of the small
IQ domain-containing proteins, PEP19, has been reported to be able to bind mRNA, in alternative to
calmodulin [159].
Coming back to lactate, this compound, possibly supplied to neurons from astrocytic
glycogenolysis, seems to be an important substrate for neuronal metabolism and LTPmaintenance [141].
In addition, during exercise, lactate originating from muscle metabolism can also be shuttled across
the BBB through monocarboxylate transporters (MCTs), to be used by brain cells [39,134,160,161].
Interestingly, increases in peripheral blood lactate levels have recently been associated with increased
circulating BDNF [162,163]. The biochemical association between the neurotrophin and lactate
production has not yet been clearly understood. However, this observation, together with the putative
role of lactate in neuron metabolism under conditions of special energy demand, suggests that lactate
can indeed represent the link between exercise and exercise-dependent improvement of cognitive
functions. Actually, memory formation and consolidation require energy, especially in conditions
of arousal and/or stress, and, as mentioned, this energy seems to mostly derive from astrocytic
glycogenolysis. In the hippocampus, exercise leads to a burst of extracellular lactate which remains at
high levels for at least 50 min and is completely blocked by inhibition of glycogenolysis, which also
blocks long-term memory [102]. An important role in memory processes is played by glutamate, and
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active uptake of glutamate by astrocytes, as already mentioned, is the basis of the astrocyte-neuron
shuttle [138].
Moreover, lactate has been recently reported to potentiate NMDA glutamate receptor-mediated
currents, which play a central role in neuronal plasticity and memory processes; in doing that, lactate
activates a cascade of molecular events which ends up with stimulation of the expression of synaptic
plasticity-related genes, such as Arc, c-Fos, and Zif268 [164].
6. Lactate as a Signaling Molecule in the Brain
As discussed above, lactate is probably a molecule with an important metabolic impact in the
brain. However, a further role is emerging [165,166]: lactate can indeed also bind a receptor of the
G protein coupled receptor (GPRs) family: GPR81, also known as HCA1 (hydroxycarboxylic acid 1) or
HCAR1 (hydroxycarboxylic acid receptor 1). This receptor is connected to a G protein (Gi) that inhibits
adenylate cyclase, thus causing a decrease of the second messenger cyclic AMP (cAMP). The mRNA
encoding GPR81 and the protein itself localize to hippocampus, neocortex and cerebellum. The protein
is concentrated in the principal neurons (for example, the pyramidal neurons in the hippocampus),
but also in the interneurons of many brain areas [167]. By electron microscopy with immunogold,
the highest concentration of the receptor was found in the somatodendritic compartment, mainly on
the post-synaptic dendritic spines of excitatory synapses [166]. Immunoreactivity was also found
on the brain capillary endothelial cells (BBB) and on the perivascular and perisynaptic astrocytic
processes. Localization of GPR81 thus suggests that lactate can have at the same time a metabolic
role and a regulatory role in the control of blood flow and synaptic function, acting as an intercellular
messenger [168]. Moreover, transduction of a signal which decreases cAMP could represent a feedback
mechanism, opposing the effect of catecholamines, which induce glycogen breakdown and production
of the lactate itself [169,170]. Possibly, signaling through GPR81 (which requires high concentrations of
lactate) may have a special role under stress conditions, such as those induced by ischemia or seizures.
Actually, it seems that lactate can contribute to signaling pathways in other ways: for example, lactate
released from astrocytes attenuates transporter-mediated uptake of prostaglandin E2, thus increasing
its external accumulation and vasodilation [171]. However, vasodilation is useful in hypoxia or, in
general, in conditions of energy deficiency, which are the conditions of high lactate production and
release. Thanks to vasodilation a higher amount of oxygen and glucose can reach the brain.
Interestingly, a different, putatively excitatory G-protein coupled receptor for lactate, which causes
an increase of cAMP, has been described in the Locus Coeruleus, but its significance is still under
study [170].
Lactate has also been reported to activate the expression of NDRG3 protein. During hypoxia,
low oxygen concentration and high lactate levels induce NDRG3 protein that, in turn, stimulates the
Raf-ERK pathway to promote angiogenesis and cell growth [172].
Moreover, Rinholm and colleagues showed that low glucose medium conditions reduce number
and myelination activity of cultured oligodendrocytes, and that the addition of lactate can rescue both
development and myelinating capacity of the cells [173].
Taken together, these observations indicate that lactate plays a very complex role in brain
metabolism and function. This role is possibly different in normal and stress/pathological conditions.
Thus a final central question is: are elevated concentrations of lactate in the brain the cause or the
consequence of stress/pathological conditions?
7. Brain Glucose Metabolism and Elevated Lactate in Pathological Conditions
In many acute as well as chronic pathological conditions, brain glucose metabolism is altered.
For example, diabetic patients undergo frequent episodes of hypoglycemia, due to the concomitant
effects of the therapy itself and the inability of the organism to elicit the physiological responses to
a low concentration of circulating glucose [174]. In these patients, as well as in nondiabetic people,
lactate infusions can reduce the response to epinephrine, thus reducing the risk of hypoglycemia, while
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causing brain lactate uptake [161,174–177]. Similar observations have been done in rats [178]. Now, as
discussed above, beside the use of lactate coming from the circulation as a substrate in the place of
glucose, an additional explanation for these observations could be that lactate, by binding to its GPR81
receptor, induces a decrease of cAMP, thus counteracting the effects of epinephrine.
In traumatic brain injury (TBI), an increase of brain glycolysis, partially relying on brain glycogen,
is observed immediately after injury, in parallel with a decrement in cerebral oxygen consumption
rate [179]. In some patients, an elevation of the pentose phosphate pathway was also observed [180].
In the days following TBI, however, glucose uptake and its use rate decrease. At the same time, many
patients show cerebral net lactate uptake [181]. A direct use of lactate in patients with TBI was actually
demonstrated by a combination of 13C-labelled microdialysis and high-resolution nuclear magnetic
resonance [182,183]. For this reason, lactate is beginning to be considered a good substrate for vascular
infusion of patients in the days after TBI; lactate indeed should enter the mitochondria to be oxidized
to pyruvate and pyruvate could be then used for fueling the TCA cycle. Alternatively, lactate could
be oxidized to pyruvate in the cytoplasm and pyruvate could enter the mitochondria. In both cases,
lactate should serve as a “glucose sparing” substrate [179,184].
Notably, on the other hand, some Authors have emphasized the uncoupling of metabolism
between neurons and astrocytes after TBI, and the production of an excessive amount of lactate, which
can be toxic, in the injured brain (“lactate storm”) [185].
In the case of ischemic insults, many in vitro studies suggest that lactate is the major
energy substrate for surviving neurons, and it has been reported that lactate can protect neurons
from glutamate-induced neurotoxicity [39,186]. Intracerebroventricular as well as intravenous
administration of lactate after transient middle cerebral artery occlusion attenuate lesion size and
improve neurologic outcome. These effects can be partially explained by the use of lactate as ametabolic
substrate and partially by its binding to GPR81, and activation of a signal transduction pathway in
neurons [187,188].
Disturbances of glucose metabolism have also been recognized in the pathogenesis of depression.
By studying in a model of prenatal stressed rats (an animal model of depression), the expression of
different enzymes involved in glycolysis, pentose phosphate pathway, and TCA cycle, data have been
collected which suggest that glycolysis is increased and TCA cycle decreased in the brain of prenatal
stressed animals, with a parallel increase of lactate [189].
A significant increase in de novo synthesis of lactate (and glutamine) was also observed in the
brain of rats which underwent experimental bile-duct ligation to simulate liver fibrosis and necrosis;
these rats are a good animal model of chronic liver disease, as they indeed develop brain edema, and
minimal hepatic encephalopathy. On the basis of these results, the Authors suggest that inhibiting
lactate synthesis could be a target in the treatment of hepatic encephalopathy [190,191].
The levels of lactate were reported to be high in the cerebrospinal fluid (CSF) of patients with
Alzheimer’s Diseases (AD) [192]. Now,  -site APP-cleaving enzyme (BACE1), one of the two enzymes
which cleave the amyloid precursor protein (APP) to give beta peptides, has an acidic optimal pH;
because of this consideration, the levels of beta peptides have been studied in cultured neuroblastoma
cells, treated with lactate. According to these studies, high levels of lactate could be a risk factor in
AD amyloidogenesis because of aberrant APP processing leading to increased generation of amyloid
peptides and APP aggregates; however, the lactate effect does not seem to be due to pH modifications,
but to increased levels of ER chaperones Grp78 and Grp94, which leads to aggresome formation [193].
On the other hand, regular physical activity and exercise are protective against many pathologies,
such as cardiovascular diseases, and dementia, including AD [130]. As we have discussed, exercise
causes an elevation of circulating lactate and this lactate can reach the brain, by crossing the
BBB. Notably, similarly good effects of exercise have been reported in Parkinson disease [194] and
Huntington’s Disease [195], as well as in multiple sclerosis [196].
As a final note, high levels of serum lactate have been reported to be non-invasive biomarkers of
malignancy for brain tumors [197].
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8. Conclusions
In conclusion, the idea that lactate is a waste product of themetabolism and amain cause of fatigue,
should no longer be considered as an indisputable truth. This molecule, instead, can be shuttled among
cells and, inside the cells, among different organelles, thanks to specific monocarboxylate carriers, and
seems to be a fuel for many cells, including neurons, in conditions of oxygen shortage.
Most importantly, it can behave as a signal, eliciting in the cells’ responses which counteract
stress, allowing at least an attempt of adaptive responses. Interestingly, exercise, which promotes
lactate production, has been recently reported to have a positive effect in many physiological as well
as pathological conditions, including brain aging and neurodegenerative diseases.
Although more research is required to better understand the real function of lactate produced
during exercise, what we have been knowing up to now is exciting and suggests that this molecule
could somehow underlie the ancient observation that a healthy (and well exercised) body hosts
a healthy mind.
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